|
May 13
|
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Cumberland Pharmaceuticals First Quarter 2024 Earnings: US$0.14 loss per share (vs US$0.013 profit in 1Q 2023)
|
|
May 8
|
Q1 2024 Cumberland Pharmaceuticals Inc Earnings Call
|
|
May 7
|
Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update
|
|
Apr 30
|
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS
|
|
Apr 2
|
NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS
|
|
Mar 7
|
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2023 Earnings Call Transcript
|
|
Mar 7
|
Cumberland Pharmaceuticals Full Year 2023 Earnings: US$0.44 loss per share (vs US$0.38 loss in FY 2022)
|
|
Mar 6
|
Q4 2023 Cumberland Pharmaceuticals Inc Earnings Call
|
|
Mar 5
|
Cumberland Pharmaceuticals Reports Annual 2023 Financial Results
|
|
Feb 27
|
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS
|
|
Nov 12
|
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q3 2023 Earnings Call Transcript
|
|
Nov 7
|
Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results
|
|
Oct 31
|
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS
|
|
Aug 8
|
Cumberland Pharmaceuticals Reports Revenue and Earnings Growth Second Quarter 2023
|